Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
Filings by filing date
News
Biz Brief
Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | 8223 Roper Road EDMONTON AB T6E 6S4 |
Tel: | N/A |
Website: | https://www.radientinc.com |
IR: | See website |
Key People | ||
Harry Kaura President, Chief Executive Officer, Director | Prakash Hariharan Chief Financial Officer | Steven Joseph Splinter Chief Technology Officer, Corporate Secretary, Director |
Business Overview |
Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles. |
Financial Overview |
For the nine months ended 31 December 2022, Radient Technologies Inc revenues decreased 14% to C$2.9M. Net loss decreased 24% to C$5.2M. Revenues reflect Manufacturing services decrease from C$17K to C$0K. Lower net loss reflects Production plant decrease of 69% to C$431K (expense), Gain on modification of long-term debt decrease from C$595K (expense) to C$248K (income). |
Employees: | 33 as of Mar 31, 2020 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $16.33M as of Dec 31, 2022 |
Annual revenue (TTM): | $3.15M as of Dec 31, 2022 |
EBITDA (TTM): | -$4.80M as of Dec 31, 2022 |
Net annual income (TTM): | -$11.30M as of Dec 31, 2022 |
Free cash flow (TTM): | -$0.98M as of Dec 31, 2022 |
Net Debt Last Fiscal Year: | $13.47M as of Dec 31, 2022 |
Shares outstanding: | 541,000,000 as of Mar 4, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |